CORD-19:58c67994f47dc6c8b552cff7de2892719259ec52 / 27404-27720 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T174","span":{"begin":0,"end":316},"obj":"Sentence"},{"id":"TextSentencer_T174","span":{"begin":0,"end":316},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The SAIL-SARS-CoV NP CTD sample contained 0.5 mM (10% D 2 O buffer) and 0.5 mM (100% D 2 O buffer) of the SAIL SARS-CoV NP CTD in NMR buffer [10 mM sodium phosphate pH 6.0, 50 mM NaCl, 1 mM EDTA, 1 mM 2,2-dimethyl-2-silapentane-5-sulfonate, 0.01% NaN 3 , 10% D 2 O, and Complete Mini protease inhibitor mix (Roche)]."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T174","span":{"begin":0,"end":316},"obj":"Sentence"}],"text":"The SAIL-SARS-CoV NP CTD sample contained 0.5 mM (10% D 2 O buffer) and 0.5 mM (100% D 2 O buffer) of the SAIL SARS-CoV NP CTD in NMR buffer [10 mM sodium phosphate pH 6.0, 50 mM NaCl, 1 mM EDTA, 1 mM 2,2-dimethyl-2-silapentane-5-sulfonate, 0.01% NaN 3 , 10% D 2 O, and Complete Mini protease inhibitor mix (Roche)]."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T133","span":{"begin":9,"end":17},"obj":"Disease"},{"id":"T134","span":{"begin":9,"end":13},"obj":"Disease"},{"id":"T135","span":{"begin":111,"end":119},"obj":"Disease"},{"id":"T136","span":{"begin":111,"end":115},"obj":"Disease"},{"id":"T16384","span":{"begin":9,"end":17},"obj":"Disease"},{"id":"T69100","span":{"begin":9,"end":13},"obj":"Disease"},{"id":"T38561","span":{"begin":111,"end":119},"obj":"Disease"},{"id":"T58216","span":{"begin":111,"end":115},"obj":"Disease"}],"attributes":[{"id":"A133","pred":"mondo_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A134","pred":"mondo_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A135","pred":"mondo_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A136","pred":"mondo_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A46719","pred":"mondo_id","subj":"T16384","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A13950","pred":"mondo_id","subj":"T69100","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A1118","pred":"mondo_id","subj":"T38561","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A84669","pred":"mondo_id","subj":"T58216","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The SAIL-SARS-CoV NP CTD sample contained 0.5 mM (10% D 2 O buffer) and 0.5 mM (100% D 2 O buffer) of the SAIL SARS-CoV NP CTD in NMR buffer [10 mM sodium phosphate pH 6.0, 50 mM NaCl, 1 mM EDTA, 1 mM 2,2-dimethyl-2-silapentane-5-sulfonate, 0.01% NaN 3 , 10% D 2 O, and Complete Mini protease inhibitor mix (Roche)]."}